Position in CYTK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$105,237,162
+$73,272,133 QoQ
Shares Held
1,235,323
+154.7% QoQ
Ownership
0.889%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 477 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 92%
None 8%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Invesco Ltd. holds $14,221,834,024 across 296 Biotechnology names. CYTK ranks #23 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,043,052 | $3,995,225,212 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,940,665 | $2,457,162,245 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
3,754,318 | $1,130,162,341 | |
| 4 | INCY |
Incyte Corp
|
4,080,461 | $462,561,050 | |
| 5 | ARGX |
Argenx SE
|
443,990 | $411,920,598 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
1,671,684 | $409,178,086 | |
| 7 | MRNA |
Moderna, Inc.
|
5,780,299 | $404,794,337 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,201,644 | $379,827,645 |
All Filings in CYTK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,237,162 | 1,235,323 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $31,965,029 | 484,980 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $13,017,946 | 204,878 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $8,642,402 | 157,249 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,503,747 | 136,312 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $20,170,635 | 501,882 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $24,355,663 | 517,765 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $26,563,203 | 503,091 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $26,840,661 | 495,398 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $92,372,583 | 1,317,538 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $103,776,397 | 1,242,980 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $34,877,102 | 1,183,880 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $49,036,208 | 1,503,256 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $51,992,553 | 1,477,481 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $66,473,500 | 1,450,753 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $68,338,189 | 1,410,489 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $21,515,164 | 547,599 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $14,674,267 | 398,649 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $34,625,712 | 759,669 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $15,263,087 | 427,059 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,347,341 | 421,796 | Shares | Defined | 2021-08-17 | |
| 2021-03-31 | $9,781,108 | 420,512 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $9,206,121 | 443,028 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $9,324,849 | 430,709 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $13,896,093 | 589,567 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,973,641 | 337,035 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||